Clinical Trial Update: Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating CCR5 blockade in HIV-positive kidney transplant recipients has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Kidney Diseases

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Kidney Diseases | Phase 2 | Status: COMPLETED | Results posted: 2023-08-21